Page last updated: 2024-08-23

lovastatin and Rheumatoid Arthritis

lovastatin has been researched along with Rheumatoid Arthritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aranow, C; Bolster, MB; Box, J; Boyle, K; Callahan, S; Cush, J; Dall'era, M; Davidson, A; Diamond, B; Frech, T; Goldmuntz, E; Huang, W; Keating, R; Keyes-Elstein, L; Kivitz, A; Mackay, M; Olech, E; Ricketts, P; Spychala, M; St Clair, W; Striebich, CC; Wasko, MC; Welch, B; York, K	1

Trials

1 trial(s) available for lovastatin and Rheumatoid Arthritis

Article	Year
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford, England), 2020, 07-01, Volume: 59, Issue:7 Topics: Adult; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; C-Reactive Protein; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Rheumatoid Factor; Severity of Illness Index; Treatment Outcome	2020

Article

Year

A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.

Rheumatology (Oxford, England), 2020, 07-01, Volume: 59, Issue:7

Topics: Adult; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; C-Reactive Protein; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Rheumatoid Factor; Severity of Illness Index; Treatment Outcome

2020